Overview
- Editors:
-
-
David S. Alberts
-
College of Medicine, Arizona Cancer Center, University of Arizona, Tucson, USA
-
Mary C. Clouser
-
Arizona Cancer Center, University of Arizona, Tucson, USA
-
Lisa M. Hess
-
School of Medicine, Deps of Pub. Health and Obstetrics and G, Indiana University, Indianapolis, IN, USA
A comprehensive review of intraperitoneal chemotherapy - Explains treatment principles and selection criteria for patients, drugs, and catheters - Presents administration guidelines, discusses novel drugs, and examines the most recent results of clinical trials - Written by highly experienced clinicians
Includes supplementary material: sn.pub/extras
Access this book
Other ways to access
Table of contents (11 chapters)
-
Front Matter
Pages i-viii
-
- David S. Alberts, Setsuko K. Chambers
Pages 1-6
-
-
-
- David S. Alberts, Mary C. Clouser
Pages 37-50
-
-
-
-
-
- Boris Kobrinsky, Franco Muggia
Pages 95-108
-
-
-
Back Matter
Pages 151-153
About this book
Intraperitoneal chemotherapy is increasingly being used as first-line treatment for ovarian cancer. Nevertheless, it is difficult for the oncologist to find a definitive text that documents both the fundamental methods required to optimize therapy and the up-to-date results of phase I, II, and III clinical trials. With this in mind, the editors of Intraperitoneal Chemotherapy have assembled a team of highly experienced clinicians and researchers to cover every aspect of the subject. The topics addressed include treatment principles, patient, drug, and catheter selection, administration guidelines, the role of hyperthermia, supportive care requirements, novel drugs, and the most recent results of clinical trials. This book will be an invaluable source of information for both practicing clinical oncologists and oncologists in training.
Editors and Affiliations
-
College of Medicine, Arizona Cancer Center, University of Arizona, Tucson, USA
David S. Alberts
-
Arizona Cancer Center, University of Arizona, Tucson, USA
Mary C. Clouser
-
School of Medicine, Deps of Pub. Health and Obstetrics and G, Indiana University, Indianapolis, IN, USA
Lisa M. Hess
About the editors
Prof. Alberts is Director of the Arizona Cancer Center in Tucson, AZ.
He led a workshop on intraperitoneal chemotherapy in January 2006 at the Gynecologic Oncology Group meeting with 400 oncologists and nurses present. He also published the results of the first ever phase III trial comparing IV to IP chemotherapy in the New England Journal of Medicine.
